MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-UP-28-0007231
Unicure India Ltd - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹369.12 Cr
▼ 12% YoY
Net profit · FY 2025
₹10.01 Cr
Net margin 2.7%
EBITDA · FY 2025
₹30.35 Cr
EBITDA margin 8.2%
Authorised capital
₹12.1 Cr
Registered with MCA
Paid-up capital
₹9.99 Cr
Issued & subscribed
Open charges
₹187.15 Cr
Satisfied ₹6.22 Cr
Company age
46 yrs
Est. 1980
Employees · EPFO
447
Provident fund records
About Unicure India Ltd
Data last updated:
Unicure India Ltd is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 July 1980 and has been in existence for over 46 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1980PLC010642. Its GSTIN is 05AAACU0405C1Z7 (Uttarakhand). The company holds 6 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹12.1 Cr and a paid-up capital of ₹9.99 Cr. It was formerly known as Unicure India Pvt Ltd and Unicure (India) Private Limited. It is led by directors including Abdul Mateen (Managing Director) and Amin Ul Aziz.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C 677 New Frineds Colony, New Delhi, Delhi, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹369.12 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹10.01 Cr (net margin 2.7%) and EBITDA of ₹30.35 Cr (EBITDA margin 8.2%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 9% over five years.
The company has about 447 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Unicure. As per MCA filings, the company has open charges of ₹187.15 Cr and satisfied charges of ₹6.22 Cr on record. Court records list 276 cases involving the company, including 167 filed by the company and 109 filed against it; 53 cases are pending. The company has 8 deals on record (4 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹29.57 Cr; the latest was in August 2024. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Rajasthan Antibiotics Ltd with revenue of ₹383.3 Cr. The company has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 87 overdue payments to 53 micro and small suppliers.
Unicure India Ltd is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0007231). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unicureindia.com.
Company details
CIN U74899DL1980PLC010642
Registration Number 010642
Incorporation Date 14 July 1980
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-UP-28-0007231
Name history
Unicure India has undergone 2 name changes throughout its history. The company was previously known as Unicure India Pvt Ltd, and Unicure (India) Private Limited. The current legal name is Unicure India Ltd.
| Company Name | Status |
|---|---|
| Unicure India Ltd | Current |
| Unicure India Pvt Ltd | Previous |
| Unicure (India) Private Limited | Previous |
CIN history
Unicure India has one previous CIN (Corporate Identification Number): U74899DL1980PTC010642. The current CIN is U74899DL1980PLC010642, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74899DL1980PLC010642 | Current |
| U74899DL1980PTC010642 | Previous |
Key People
Abdul Mateen Managing Director Amin Ul Aziz Director Qazi Salim Riaz Director Appointed In Casual Vacancy Recognitions & Rankings of Unicure India
Contact details
Unicure India Ltd's registered office is in New Delhi, Delhi. Its website is unicureindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC 677 New Frineds Colony, New Delhi, Delhi, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Unicure India Ltd, buy the company report.
Comprehensive company report
Unicure India Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Unicure India operates one associated brand: Unicure. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| An R&D company manufacturing drugs for multiple therapeutic areas. | unicureindia.com |
Business activity
The main business activity of Unicure India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Unicure India Ltd, buy the company report.
Financials of Unicure India Ltd
FY 2025 filings availableUnicure India Ltd reported revenue of ₹369.12 Cr (down 12% YoY) for FY 2025.
Revenue · FY 2025
₹369.12 Cr ▼ 12%
Net profit · FY 2025
₹10.01 Cr margin 2.7%
EBITDA · FY 2025
₹30.35 Cr margin 8.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 12%
3 years · compounded
▲ 18%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 17%
5 years · compounded
▲ 17%
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30.35 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.01 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.2% | ||||
| Net Profit Margin | 2.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unicure India Ltd, buy the company report.
Board of directors of Unicure India Ltd
Unicure India has 5 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amin Ul Aziz Also directs: Bhujadhari Vincom Private Limited, F & S Trading Private Limited, Rosebud Tradelink Private Limited and 2 more | Director | 30 Dec 2024 | 1 Years 10 Months | Current |
| Qazi Salim Riaz | Director Appointed In Casual Vacancy | 03 Aug 2024 | 2 Years 2 Months | Current |
| Abdul Mateen | Managing Director | 14 Jul 1980 | 46 Years 3 Months | Current |
| Kashish Aziz | Director | 30 Dec 2024 | 1 Years 10 Months | Current |
| Mohd Zubair | Director | 30 Dec 2024 | 1 Years 10 Months | Current |
Peer comparison
Unicure India Ltd is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rajasthan Antibiotics Ltd | ₹383.3 Cr (FY 2025) | 1.0% | New Delhi, Delhi, India | |||
| Marc Laboratories Limited | ₹383.21 Cr (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Caplin Steriles Limited | ₹377.24 Cr (FY 2025) | 18.0% | Chennai, Tamil Nadu, India | |||
| NGL Fine-Chem Limited | ₹376.89 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Unicure India Ltdthis company | ₹369.12 Cr (FY 2025) | ₹10.01 Cr | 2.7% | -12.0% | 447 | New Delhi, Delhi, India |
| Beta Drugs Limited | ₹368.79 Cr (FY 2025) | 24.0% | Baddi, Himachal Pradesh, India | |||
| Brawn Laboratories Limited | ₹368.56 Cr (FY 2025) | 15.0% | Delhi, India | |||
| M. J. Biopharm Private Limited | ₹367.26 Cr (FY 2025) | 24.0% | Pune, Maharashtra, India | |||
| Biochem Pharmaceutical Industries Limited Part IX | ₹366.61 Cr (FY 2016) | 15.0% | Ahmedabad, Gujarat, India | |||
| Kopran Research Laboratories Limited | ₹365.89 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Unicure India Ltd, buy the company report.
Auditor
Unicure India Ltd is audited by H.K.Dua & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H.K.Dua & Co. | FY 2024 | 000581N |
Shareholding
The shareholding of Unicure India Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Unicure India Ltd, buy the company report.
Charges & borrowings
Open charges
₹187.15 Cr
Satisfied charges
₹6.22 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Jun 2025 | 101136515 | Hdfc Bank Limited | ₹45 Lakh | Open | |
| 13 Jun 2025 | 101145764 | Hdfc Bank Limited | ₹23.05 Lakh | Open | |
| 01 Oct 2024 | 100984447 | Hdfc Bank Limited | ₹38.94 Lakh | Open | |
| 17 May 2024 | 100919402 | Others | ₹25 Lakh | Open | |
| 16 Mar 2024 | 100895885 | Others | ₹50 Lakh | Open |
To see the full charge records of Unicure India Ltd, buy the company report.
Total charge records: 20 View all charges
Deals & funding
Unicure India Ltd has 8 deals on record (4 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹29.57 Cr; the latest was in August 2024.
Total deals
8
Secondary share transfers
4
Funding rounds
3
Rights issue
1
Disclosed funding
₹29.57 Cr
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2024 | Rights issue | ₹2.51 Cr | Investors: Rosebud Tradelink Private Limited , 3 individuals |
| Feb 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Nov 2017 | Funding round | ₹29 Cr | Investors: Rosebud Tradelink Private Limited |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Mar 2014 | Funding round | ₹46 Lakh | Investors: 4 individuals |
To see the full deal history of Unicure India Ltd, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Unicure India Ltd has 276 court cases on record: 167 filed by Unicure India, 109 filed against it. 53 cases are pending and 223 are disposed.
Total cases
276
Filed by the company
167
Filed against the company
109
Pending
53
Disposed
223
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 191 | 94 | 35 |
| High courts | 83 | 13 | 18 |
| NCLT | 2 | 2 | 0 |
Cases on record (5 of 276)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed by the company against The Karnataka State Medical Supplies Corporation Ltd., and 1 other | Pending |
| Gauhati High Court | Writ petition | Filed by the company against The Assam Medical Services Corporation Limited and 1 other | Disposed |
| High Court | Writ petition | Filed by the company against Kerala Medical Services Corporation Ltd and 2 others | Disposed |
| High Court | Writ petition | Filed by the company against The Karnataka State Medical Supplies Corporation Ltd and 1 other | Disposed |
| District court, Kottayam, Kerala | Criminal case | Filed against the company by an individual | Pending |
To see the full case history of Unicure India Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Unicure India Ltd has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 87 overdue payments to 53 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 53)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Bio-Gen Extracts Private Limited | |||
| Amit Hydrocolloids | |||
| Roaq Chemicals Pvt. Ltd. |
To see the full MSME payment records of Unicure India Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Unicure India Ltd has a workforce of 447 employees on its EPFO records as of Apr 24, 2024, across 3 active EPFO establishments.
Employee count
447
Active EPFO establishments
3
Employee growth
71.26%
GST
Unicure India has 6 GST registrations: 5 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
6
Active
5
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAACU0405C1Z7 | Uttarakhand | Active | 01 Jul 2017 |
| 09AAACU0405C1ZZ | Uttar Pradesh | Active | 01 Jul 2017 |
| 08AAACU0405C1Z1 | Rajasthan | Active | 01 May 2018 |
| 19AAACU0405C1ZY | West Bengal | Active | 01 May 2018 |
To see the full GST registrations and return filing status of Unicure India Ltd, buy the company report.
Recent activity
Unicure India Ltd has 15 board changes on record since 1980: 6 appointments and 9 cessations. The latest: Amin Ul Aziz was appointed as Director on 30 Dec 2024.
AGM
Unicure India Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Canara Bank of Rs. 142.00 Cr registered on 27 Mar 1985 with Charge ID 90052025 was modified on 16 Sep 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.45 Cr with Charge ID 101136515 was registered on 17 Jun 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.23 Cr with Charge ID 101145764 was registered on 13 Jun 2025.
Filing
Unicure India Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Amin Ul Aziz was appointed as Director.
Appointed
Kashish Aziz was appointed as Director.
Appointed
Mohd Zubair was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.39 Cr with Charge ID 100984447 was registered on 01 Oct 2024.
Appointed
Qazi Salim Riaz was appointed as Director Appointed In Casual Vacancy.
Charges
A charge with Hdfc Bank Limited of Rs. 43.00 Cr registered on 16 Jan 2021 with Charge ID 100415034 was modified on 24 May 2024.
Charges
A charge with Others amounted to Rs. 0.25 Cr with Charge ID 100919402 was registered on 17 May 2024.
45 earlier events are in the company report.
Frequently asked questions
Unicure India is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 July 1980 (46+ years old) and is registered under CIN U74899DL1980PLC010642.
Unicure India has 5 current directors:
- Abdul Mateen - Managing Director
- Amin Ul Aziz - Director
- Qazi Salim Riaz - Director Appointed In Casual Vacancy
- Kashish Aziz - Director
- Mohd Zubair - Director
The latest financial statements of Unicure India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Unicure India is 05AAACU0405C1Z7, registered in Uttarakhand. The company has 6 GST registrations in all, of which 5 are active and 1 is cancelled or inactive. Other active GSTINs include 09AAACU0405C1ZZ (Uttar Pradesh), 08AAACU0405C1Z1 (Rajasthan), 19AAACU0405C1ZY (West Bengal).
The CIN (Corporate Identification Number) of Unicure India is U74899DL1980PLC010642. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unicure India has 276 court cases on record: 167 filed by the company and 109 filed against it. 53 are pending. Most are in the district courts.
Unicure India was incorporated on 14 July 1980, making it 46+ years old. It is registered with the Registrar of Companies, Delhi.
Unicure India has 8 deals on record (4 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹29.57 Cr; the latest was in August 2024.
The peers of Unicure India by revenue are Rajasthan Antibiotics Ltd, Marc Laboratories Limited, Caplin Steriles Limited, NGL Fine-Chem Limited, Beta Drugs Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amin Ul Aziz was appointed as Director on 30 Dec 2024. Kashish Aziz was appointed as Director on 30 Dec 2024. Mohd Zubair was appointed as Director on 30 Dec 2024. Unicure India has 15 board changes on record in total.
Yes, Unicure India is registered as a medium enterprise under Udyam registration (number: UDYAM-UP-28-0007231).
Unicure India has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 87 overdue payments to 53 micro and small suppliers. The latest return was filed on 17 Nov 2019.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages